Pear Therapeutics, Inc. (PEAR): Price and Financial Metrics
PEAR Price/Volume Stats
|Current price||$0.03||52-week high||$6.74|
|Prev. close||$0.05||52-week low||$0.03|
|Day high||$0.04||Avg. volume||7,748,841|
|50-day MA||$0.62||Dividend yield||N/A|
|200-day MA||$1.49||Market Cap||4.17M|
PEAR Stock Price Chart Interactive Chart >
Pear Therapeutics, Inc. (PEAR) Company Bio
Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts.
PEAR Latest News Stream
|Loading, please wait...|
PEAR Latest Social Stream
View Full PEAR Social Stream
Latest PEAR News From Around the Web
Below are the latest news stories about PEAR THERAPEUTICS INC that investors may wish to consider to help them evaluate PEAR as an investment opportunity.
We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning!
Mind Medicine (MNMD) stock is on the rise Friday after releasing positive results from a Phase 2 clinical trial of lysergide (LSD).
National CineMedia (NCMI) stock is on the move Friday as the movie theater ad company's shares continue to see wild swings this week.
Pear Therapeutics (PEAR) stock is falling on Friday after the company's recent bankruptcy filing continues to weigh on its shares.
It's time for another dive into the biggest pre-market stock movers with all the latest news traders need to know about for Friday!
PEAR Price Returns